| Literature DB >> 35570252 |
Rafaella Rodrigues Gomes1, Livia Fávaro Zeola2, Tiago Augusto Quirino Barbosa1, Alfredo Júlio Fernandes Neto3, Guilherme de Araujo Almeida4, Paulo Vinícius Soares5.
Abstract
BACKGROUND: This study aimed to assess the distribution of non-carious cervical lesions (NCCLs) by tooth type, investigate the prevalence of NCCLs in patients undergoing orthodontic treatment, and identify the possible associated factors.Entities:
Keywords: Non-carious cervical lesions; Orthodontics; Tooth abrasion; Tooth movement techniques; Tooth wear
Mesh:
Year: 2022 PMID: 35570252 PMCID: PMC9108122 DOI: 10.1186/s40510-022-00409-4
Source DB: PubMed Journal: Prog Orthod ISSN: 1723-7785 Impact factor: 3.247
Fig. 1Prevalence of non-carious cervical lesions in permanent teeth subjected to orthodontic treatment (from first molar to first molar)
Distribution of variables
| Variable | Patients (N = 160) |
|---|---|
| Gender | |
| Female | 99 (62%) |
| Male | 61 (38%) |
| Age | |
| Up to 20 years | 94 (59%) |
| 21–35 years | 34 (21%) |
| > 35 years | 32 (20%) |
| Number of activation sessions | |
| 6–18 sessions | 27 (17%) |
| 19–36 sessions | 113 (71%) |
| > 36 sessions | 20 (13%) |
| Angle classification | |
| Class I | 76 (48%) |
| Class II | 74 (46%) |
| Class III | 10 (6%) |
| Facial pattern | |
| Mesiofacial | 54 (34%) |
| Brachyfacial | 10 (6%) |
| Dolichofacial | 96 (60%) |
| Compensatory treatment | |
| No | 110 (69%) |
| Yes | 50 (31%) |
| Retreatment | |
| No | 118 (74%) |
| Yes | 42 (26%) |
Poisson regression analyses of the association between non-carious cervical lesions and the independent variables
| Variable | PR (95% CI) | Adjusted PR (95% CI) | ||
|---|---|---|---|---|
| Age (reference: up to 20 years) | 1 | 1 | ||
| 21–35 years | 1.13 (1.05–1.23) | 0.002* | 1.14 (1.05–1.25) | < 0.002* |
| > 35 years | 1.17 (1.08–1.25) | < 0.001* | 1.19 (1.10–1.29) | < 0.001* |
| Gender (reference: women) | 1 | 1 | ||
| Men | 1.02 (0.94–1.10) | 0.564 | 1.05 (0.97–1.14) | 0.158 |
| Angle classification (reference: Class I) | 1 | 1 | ||
| Class II | 1.05 (0.97–1.13) | 0.213 | 1.00 (0.93–1.09) | 0.815 |
| Class III | 1.11 (1.00–1.23) | 0.046* | 1.09 (0.98–1.22) | 0.095 |
| Facial pattern (reference: mesofacial) | 1 | 1 | ||
| Brachyfacial | 1.04 (0.95–1.13) | 0.308 | 1.04 (0.96–1.13) | 0.251 |
| Dolichofacial | 1.11 (0.98–1.25) | 0.079 | 1.08 (0.95–1.22) | 0.198 |
| Number of activation sessions (reference: 6 to 18 sessions) | 1 | |||
| 19–36 sessions | 1.03 (0.92–1.15) | 0.558 | 1.07 (0.97–1.18) | 0.161 |
| > 36 sessions | 1.08 (0.95–1.23) | 0.222 | 1.11 (0.97–1.28) | 0.114 |
| Compensatory treatment (reference: no) | 1 | 1 | ||
| Yes | 0.99 (0.92–1.08) | 0.960 | 0.98 (0.91–1.06) | 0.682 |
| Retreatment (reference: no) | 1 | 1 | ||
| Yes | 1.07 (0.99–1.15) | 0.057 | 1.03 (0.96–1.11) | 0.320 |
PR prevalence ratio, CI confidence interval
*Significant difference (Poisson regression model, p < 0.05)